⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL1885701 | 0.60 | — | — | |
| Acetonitrile SCHEMBL1330705 | 0.54 | — | — | |
| Acetonitrile SCHEMBL1331294 | 0.54 | — | — | |
| Acetonitrile SCHEMBL10051948 | 0.54 | — | — | |
| Acetonitrile SCHEMBL6693864 | 0.54 | — | — | |
| Acetonitrile SCHEMBL2562219 | 0.54 | TSHR (0.36) | — | |
| Acetonitrile SCHEMBL10523138 | 0.54 | — | — | |
| Acetonitrile SCHEMBL10524251 | 0.54 | TSHR (0.36) | — | |
| Acetonitrile SCHEMBL1330624 | 0.54 | — | — | |
| Acetonitrile SCHEMBL350933 | 0.54 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4724505-A1 | NON-COORDINATED ALKYLALUMINUM FREE ANION MODIFIED ALUMOXANES AND METHODS THEREOF | ExxonMobil Technology and Engineering Company (US) | 2026-04-15 | — | — | EP | claimed |
| WO-2024253831-A1 | NON-COORDINATED ALKYLALUMINUM FREE ANION MODIFIED ALUMOXANES AND METHODS THEREOF | ExxonMobil Technology and Engineering Company (US) | 2024-12-12 | — | — | WO | claimed |
| EP-4724505-A1 | NON-COORDINATED ALKYLALUMINUM FREE ANION MODIFIED ALUMOXANES AND METHODS THEREOF | ExxonMobil Technology and Engineering Company (US) | 2026-04-15 | — | — | EP | disclosed |
| WO-2024253831-A1 | NON-COORDINATED ALKYLALUMINUM FREE ANION MODIFIED ALUMOXANES AND METHODS THEREOF | ExxonMobil Technology and Engineering Company (US) | 2024-12-12 | — | — | WO | disclosed |
| US-12054493-B2 | Hepatitis B antiviral agents | ENANTA PHARMACEUTICALS, INC. (US) | 2024-08-06 | — | — | US | disclosed |
| EP-3426245-B1 | HEPATITIS B ANTIVIRAL AGENTS | ENANTA PHARM INC (US) | 2022-12-14 | — | — | EP | disclosed |
| EP-1996577-B1 | HETEROCYCLIC SUBSTITUTED PYRIDINE COMPOUNDS WITH CXCR3 ANTAGONIST ACTIVITY | MERCK SHARP & DOHME (US) | 2016-02-10 | — | — | EP | disclosed |
| EP-1848710-B1 | HETEROCYCLIC SUBSTITUTED PIPERAZINES WITH CXCR3 ANTAGONIST ACTIVITY | MERCK SHARP & DOHME (US) | 2013-10-16 | — | — | EP | disclosed |
| EP-1858888-B1 | HETEROARYL SUBSTITUTED PYRAZINYL-PIPERAZINE-PIPERIDINES WITH CXCR3 ANTAGONIST ACTIVITY | MERCK SHARP & DOHME (US) | 2013-04-17 | — | — | EP | disclosed |
| EP-2041117-B1 | HETEROCYCLIC SUBSTITUTED PIPERAZINE COMPOUNDS WITH CXCR3 ANTAGONIST ACTIVITY | MERCK SHARP & DOHME (US) | 2012-08-22 | — | — | EP | disclosed |
| EP-1856098-B1 | PYRAZINYL SUBSTITUTED PIPERAZINE-PIPERIDINES WITH CXCR3 ANTAGONIST ACTIVITY | SCHERING CORP (US) | 2012-08-01 | — | — | EP | disclosed |
| WO-2006088840-A1 | NOVEL HETEROCYCLIC SUBSTITUTED PYRIDINE OR PHENYL COMPOUNDS WITH CXCR3 ANTAGONIST ACTIVITY | SCHERING CORPORATION (US) | 2006-08-24 | — | — | WO | disclosed |
| WO-2006088920-A1 | AMINE-LINKED PYRIDYL AND PHENYL SUBSTITUTED PIPERAZINE-PIPERIDINES WITH CXCR3 ANTAGONIST ACTIVITY | SCHERING CORPORATION (US) | 2006-08-24 | — | — | WO | disclosed |
| WO-2006088921-A2 | PYRAZINYL SUBSTITUTED PIPERAZINE-PIPERIDINES WITH CXCR3 ANTAGONIST ACTIVITY | SCHERING CORPORATION (US) | 2006-08-24 | — | — | WO | disclosed |
| US-20050038260-A1 | Intermediate for biotin and process for producing the same | API CORPORATION (JP) | 2005-02-17 | — | — | US | disclosed |
| EP-1462444-A1 | INTERMEDIATE FOR BIOTIN AND PROCESS FOR PRODUCING THE SAME | TANABE SEIYAKU CO., LTD. (JP) | 2004-09-29 | — | — | EP | disclosed |
| EP-0469432-A1 | Process for the production of cyanohydantoines | MERCK PATENT GmbH (DE) | 1992-02-05 | — | — | EP | disclosed |
| US-4694090-A | Chroman compounds useful as analgerics and antioxidants | KURARAY CO., LTD. (JP) | 1987-09-15 | — | — | US | disclosed |
| EP-0183869-A1 | Chroman compounds and their use | KURARAY CO., LTD. (JP) | 1986-06-11 | — | — | EP | disclosed |
| US-3954811-A | PROSTAGLANDIN INTERMEDIATES | SUMITOMO CHEMICAL CO., LTD. (JA) | 1976-05-04 | — | — | US | disclosed |